Day: February 18, 2025
Bíldudalur, 18 February 2025
Icelandic Salmon is the parent company of Arnarlax and its subsidiaries, which are involved in salmon farming and processing in Iceland. The companies are collectively referred to as “Icelandic Salmon” or the “Group”.
With determined efforts in the fourth quarter of 2024, Icelandic Salmon stabilized the biological conditions in the sea after having experienced significant challenges in the winter-spring 2023‑24, resulting in higher harvest volumes and weights, and good sea lice control.
To further strengthen the Group’s financial position, the group has agreed on an extension to its sustainability-linked financing agreement with DNB and Danske Bank. This agreement provides additional funding of EUR 65 million, increasing the total loan facility to EUR 160 million.
In the fourth quarter...
SalMar – Satisfactory results and good biological development towards the end of the quarter
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
The fourth quarter of 2024 marks the end of a challenging year for SalMar. However, biological conditions and results improved significantly towards the end of the year, providing brighter prospects for 2025.
Operational EBIT for Norway was NOK 1,485 million in the fourth quarter of 2024. The harvest volume was 67,300 tonnes, and operational EBIT per kg was NOK 22.1. Operational EBIT for the group was NOK 1,489 million in the fourth quarter of 2024. The harvest volume was 73,800 tonnes, and operational EBIT per kg was NOK 20.2.
The farming segments in Norway had a good development throughout the quarter and delivered strong results. Sales and industry contributed positively with their efficient and flexible operational setup, delivering a good result.
For SalMar Aker Ocean, the production cycles for both Arctic Offshore Farming and Ocean...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
Written by Customer Service on . Posted in Public Companies.
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025
Priority Review granted based on positive pivotal results demonstrating significant improvements in sustained disease remission with Dupixent compared to placebo
BP is a chronic, debilitating and relapsing skin disease with underlying type 2 inflammation characterized by intense itch and blisters, reddening of the skin and painful lesions
TARRYTOWN, N.Y. and PARIS, Feb. 18, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) to treat adults with bullous pemphigoid (BP).
The sBLA is supported by...
Trust Stamp Partners with Digital Platformer to Strengthen Security in Digital Identity and Financial Services
Written by Customer Service on . Posted in Public Companies.
Trust Stamp and Digital Platformer unite to establish a strategic partnership, delivering an integrated solution that combines Trust Stamp’s advanced identity verification capabilities with Digital Platformer’s cutting-edge decentralized security solutions
This joint initiative aims to enhance financial security, identity authentication, and regulatory compliance across multiple industries, ensuring a seamless and privacy-first user experience
Tokyo, Japan, Feb. 17, 2025 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™, and Digital Platformer, a leader in decentralized solutions, have signed a Memorandum of Understanding (MOU) to collaborate on innovative technologies that enhance financial security, identity verification, and privacy protection, with the intention of the parties...
EnWave to Report First Quarter Financial Results on February 24, 2025 and Host Investor Conference Call
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today it will report its financial results for the first quarter ended December 31, 2024 on Monday, February 24, 2025 before the market opens. The financial statements and MD&A will be available on SEDAR at www.sedarplus.ca and on the Company’s website.
The Company has scheduled a conference call to discuss the results for Q1 2025 and business outlook on Monday, February 24, 2025 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Dylan Murray, Chief Financial Officer will present EnWave’s results and host a question and answer period.
Conference Call Details:Date:
February 24, 2025Time:
7:00am PST / 10:00am ESTParticipant...
LGI Homes Opens Two Communities in the Oklahoma City Market
Written by Customer Service on . Posted in Public Companies.
The Keystone Plan by LGI Homes at Hollow BrookThe Keystone Plan by LGI Homes at Hollow Brook features four bedrooms, two bathrooms, and a spacious family room.OKLAHOMA CITY, Feb. 17, 2025 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) announced the recent opening of two new communities in the Oklahoma City market: The Enclave at Creekside Village and Hollow Brook. Both communities offer prospective homeowners high-quality, newly constructed homes in prime locations, designed with family living in mind.
The Enclave at Creekside Village – Yukon, OK
Located in the charming town of Yukon, The Enclave at Creekside Village provides homebuyers with a selection of spacious one- and two-story floor plans ranging from 1,152 to 2,483 square feet. Homes in this community feature three to five bedrooms and come equipped with LGI...
HYTN and A1 Cannabis Announce Collaboration Agreements to Scale Production of Cannabis Products
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Feb. 17, 2025 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has entered into a comprehensive collaboration (the “Collaboration”) with A1 Cannabis Inc. (“A1”), owner of Summit Cannabis Beverages (“Summit”). Through the Collaboration, the Company and A1 seek to enhance operational efficiency and expand both companies’ presence in the cannabis beverage market.
The Collaboration is governed by both a manufacturing agreement and a consulting agreement with a letter of understanding tying them together (the “Agreements”) and has a three-year term. The Agreements allow A1 to transition its complete cannabis product...
Exodus Movement, Inc. Announces Offer to Acquire Banxa Holdings Inc. has Expired
Written by Customer Service on . Posted in Mergers And Acquisitions.
OMAHA, Neb., Feb. 17, 2025 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced that its previously announced offer for the acquisition of all of the issued and outstanding common shares of Banxa Holdings Inc. (TSXV: BNXA) (“Banxa”) has expired without reaching an agreement with Banxa.
Exodus will remain responsible stewards of capital with a disciplined approach to acquisitions.
About Exodus
Exodus is a financial technology leader empowering individuals and businesses with secure, user-friendly crypto software solutions. Since 2015, Exodus has made digital assets accessible to everyone through its multi-asset crypto wallets prioritizing design and ease of use.
With self-custodial wallets, Exodus puts customers in full...